| Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now |
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective. |
seekingalpha.com |
2025-02-27 10:15:00 |
Czytaj oryginał (ang.) |
| U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount |
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact profits. |
seekingalpha.com |
2025-02-26 06:10:00 |
Czytaj oryginał (ang.) |
| Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1) |
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains. |
seekingalpha.com |
2025-02-24 00:21:37 |
Czytaj oryginał (ang.) |
| Elevance Health Bolsters Employer Insurance Business |
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an Elevance spokeswoman said. |
forbes.com |
2025-02-17 20:04:50 |
Czytaj oryginał (ang.) |
| Alphabet's Verily to sell Granular insurance business to Elevance Health |
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re Group. |
cnbc.com |
2025-02-06 21:11:58 |
Czytaj oryginał (ang.) |
| My Top 15 High-Growth Dividend Stocks For February 2025 |
The SPDR S&P 500 ETF Trust starts 2025 on a positive note gaining 2.67% in January. The Top 15 dividend growth stocks for February 2025 offer an average dividend yield of 1.64% and appear to be about 25% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 11.03% compound annual growth rate. |
seekingalpha.com |
2025-02-03 17:15:50 |
Czytaj oryginał (ang.) |
| 5 Stocks With Above-Market Yields Just Raised Payments Further |
With the stock market going through its first earnings season of 2025, companies are making important announcements. This includes the approval of share buyback programs, as well as dividend increases. |
marketbeat.com |
2025-01-30 10:00:04 |
Czytaj oryginał (ang.) |
| Billionaire Investor Sold These 5 Stocks And Loading Up On These Companies Instead |
According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the iconic hedge fund founded by Julian Robertson in 1980. |
247wallst.com |
2025-01-29 11:42:24 |
Czytaj oryginał (ang.) |
| Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound |
The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes. |
marketbeat.com |
2025-01-27 09:30:08 |
Czytaj oryginał (ang.) |
| Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums |
ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership partially offset the positives. |
zacks.com |
2025-01-23 15:46:13 |
Czytaj oryginał (ang.) |
| Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript |
Elevance Health, Inc. (NYSE:ELV ) Q4 2024 Earnings Conference Call January 23, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwood - President, Government Health Benefits Pete Haytaian - President, Carelon Morgan Kendrick - President, Commercial Health Benefits Conference Call Participants A.J. Rice - UBS Lance Wilkes - Bernstein Stephen Baxter - Wells Fargo Lisa Gill - JPMorgan Andrew Mok - Barclays Ryan Langston - Cowen Justin Lake - Wolfe Research Josh Raskin - Nephron Research Dave Windley - Jefferies Joanna Gajuk - Bank of America Erin Wright - Morgan Stanley Gabrielle Ingoglia - Cantor Fitzgerald George Hill - Deutsche Bank Scott Fidel - Stephens Michael Hall - Baird Whit Mayo - Leerink Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. |
seekingalpha.com |
2025-01-23 14:15:45 |
Czytaj oryginał (ang.) |
| Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend |
Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend. |
investopedia.com |
2025-01-23 14:06:03 |
Czytaj oryginał (ang.) |
| Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say |
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-01-23 12:36:34 |
Czytaj oryginał (ang.) |
| Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5% |
On Thursday, Elevance Health Inc. ELV reported fourth-quarter revenues of $44.99 billion, up 6% year-over-year, slightly higher than the consensus of $44.86 billion. |
benzinga.com |
2025-01-23 10:54:04 |
Czytaj oryginał (ang.) |
| Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates |
Elevance Health (ELV) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares to earnings of $5.62 per share a year ago. |
zacks.com |
2025-01-23 10:11:09 |
Czytaj oryginał (ang.) |
| Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress |
Despite a 29% drop in Elevance Health's stock, I maintain a strong buy rating due to a DCF price target of $549.60, indicating 43% upside. ELV's shift towards managed care, with strong industry tailwinds, supports sustainable margin expansion and revenue growth, making it a compelling investment. Regulatory risks around Pharmacy Benefit Management are mitigated by CarelonRx's diversified revenue streams and a healthy margin of safety in my modeling. |
seekingalpha.com |
2025-01-23 09:42:44 |
Czytaj oryginał (ang.) |
| Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. |
The health insurer's fourth-quarter adjusted earnings top analysts' estimates. |
barrons.com |
2025-01-23 09:35:00 |
Czytaj oryginał (ang.) |
| Elevance Health earnings boost health-insurance stocks after upbeat outlook |
UnitedHealth, Humana and Centene all rally premarket |
marketwatch.com |
2025-01-23 09:13:00 |
Czytaj oryginał (ang.) |
| Elevance beats quarterly profit estimates on lower-than-expected medical costs |
Elevance beat Wall Street estimates for quarterly profit on Thursday, as the health insurer spent less than expected on the medical costs of its members. |
reuters.com |
2025-01-23 08:07:58 |
Czytaj oryginał (ang.) |
| Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook |
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we deliver value to the members and care providers we serve by ensuring simple, affordable, and accessible care. Our fourth quarter results demonstrate tangible progress in improving our operations in response to the dynamic environment facing the industry. As we look to 2025, we remain r. |
businesswire.com |
2025-01-23 08:00:00 |
Czytaj oryginał (ang.) |
| My Top 15 High Growth Dividend Stocks For January 2025 |
The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1.21% and appear to be about 27% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 10.33% compound annual growth rate. |
seekingalpha.com |
2025-01-03 00:49:14 |
Czytaj oryginał (ang.) |
| Elevance Health Is An Undervalued Healthcare Juggernaut |
Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging population and increased life expectancy, driving long-term demand for healthcare services. Key risks include rising healthcare costs and a shrinking Medicaid member base, impacting margins and free cash flow. |
seekingalpha.com |
2024-12-26 05:01:17 |
Czytaj oryginał (ang.) |
| Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell? |
ELV is reallocating resources to more profitable areas and making prudent acquisitions. |
zacks.com |
2024-12-20 18:01:18 |
Czytaj oryginał (ang.) |
| Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025 |
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperformed the market with 27% less volatility. |
seekingalpha.com |
2024-12-12 09:00:00 |
Czytaj oryginał (ang.) |
| Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders |
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey. |
globenewswire.com |
2024-12-12 00:54:00 |
Czytaj oryginał (ang.) |
| Elevance Health: A Quality Underpriced Stock Returning To Health |
Elevance Health has shown robust financial performance, with a 9.1% revenue CAGR and 13.7% EPS growth over the past decade. Despite recent share price weakness, ELV's long-term fundamentals remain strong, presenting an investment opportunity. ELV's valuation is attractive, with a forward PE of 11.2x, lower than its 10-year average, and potential upside driven by AI integration. |
seekingalpha.com |
2024-12-11 12:44:38 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 11th |
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024. |
zacks.com |
2024-12-11 06:50:18 |
Czytaj oryginał (ang.) |
| Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal |
When Anthem Blue Cross Blue Shield said it will no longer pay for anesthesia care if the surgery or procedure exceeds an arbitrary time limit, parent company Elevance Health Inc ELV faced backlash and reneged on the policy change. |
benzinga.com |
2024-12-06 14:35:04 |
Czytaj oryginał (ang.) |
| Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses |
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-12-04 15:18:00 |
Czytaj oryginał (ang.) |
| My Top 15 High-Growth Dividend Stocks For December 2024 |
The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and appear to be about 22% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 12.41% compound annual growth rate. |
seekingalpha.com |
2024-12-02 08:00:00 |
Czytaj oryginał (ang.) |
| Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses |
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-11-18 13:55:00 |
Czytaj oryginał (ang.) |
| Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript) |
Elevance Health, Inc. (NYSE:ELV ) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J. |
seekingalpha.com |
2024-11-15 16:13:09 |
Czytaj oryginał (ang.) |
| Elevance Health Declines 20% in 3 Months: Time to Sell the Stock? |
ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which raise concerns among investors. |
zacks.com |
2024-11-12 16:00:26 |
Czytaj oryginał (ang.) |
| Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses |
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. |
globenewswire.com |
2024-11-07 18:44:00 |
Czytaj oryginał (ang.) |
| Elevance Health Announces Appearance at UBS Global Healthcare Conference |
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unab. |
businesswire.com |
2024-11-05 18:05:00 |
Czytaj oryginał (ang.) |
| My Top 15 High-Growth Dividend Stocks For November 2024 |
The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% and appear to be about 23% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved an 11.33% compound annual growth rate. |
seekingalpha.com |
2024-11-03 16:44:04 |
Czytaj oryginał (ang.) |
| Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion |
INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevance Health Champion. Designed to help increase awareness for critical health challenges and raise funds for local organizations that are making a healthy difference in their communities, the Elevance Health Champion program recognizes professional athletes and organizations who have dedicated their life to leading hea. |
businesswire.com |
2024-10-29 11:00:00 |
Czytaj oryginał (ang.) |
| AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds |
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% senior unsecured bonds, due 2026; $750 million, 4.750% senior unsecured bonds, due 2030; $750 million, 4.95% senior unsecured bonds, due 2031; $1.2 billion, 5.2% senior unsecured bonds, due 2035; $1.35 billion, 5.7% senior unsecured bonds, due 2055; and $800 million, 5.85% senior unsecured bonds, due. |
businesswire.com |
2024-10-24 14:16:00 |
Czytaj oryginał (ang.) |
| 'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz |
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more. |
youtube.com |
2024-10-21 18:41:56 |
Czytaj oryginał (ang.) |
| What's Behind The 15% Fall For Elevance Health Stock? |
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings of $8.37 per share, compared to the street estimates of $43.5 billion and $9.66, respectively. |
forbes.com |
2024-10-21 15:39:26 |
Czytaj oryginał (ang.) |